Clearmind Medicine Says Recently Signed A Non-binding Term Sheet With Dr Glitter Pty Ltd For Mutual Development In ActivCrystal Format
Clearmind Medicine Says Recently Signed A Non-binding Term Sheet With Dr Glitter Pty Ltd For Mutual Development In ActivCrystal Format
Clearmind Medicine表示最近與Dr Glitter Pty Ltd簽署了一份非約束性條款清單，以共同開發ActivCrystal格式。
The two companies plan to collaborate on the development and commercialization of Clearmind's proprietary MEAI-based alcohol substitute and Dr Glitter Pty Ltd's proprietary ActivCrystal technology. The term sheet outlines preliminary terms that, upon the mutual agreement of the parties, will be memorialized in a definitive agreement that sets forth a framework for advancing Clearmind and Dr Glitter Pty Ltd's groundbreaking innovations.
這兩家公司計劃在Clearmind的專有MEAI基礎酒精替代品和Dr Glitter Pty Ltd的專有ActivCrystal科技的開發和商業化方面進行合作。條款清單概述了初步條款，這些條款在雙方達成共識後，將在一份確定性的協議中明確，設定推動Clearmind和Dr Glitter Pty Ltd開創性創新的框架。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。